Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients
Clinical trial NCT01155063 · TERMINATED
Trial details
- NCT number
- NCT01155063
- Sponsor
- Pfizer
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2010-09-01
- Primary completion
- 2011-09-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.